John Armitage
Egerton Capital
John Armitage GE HealthCare Technologies Inc stake
total: 222
Egerton Capital GEHC trades
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 3
- Held since:
- 2023 Q4
- Held for:
- 5 quarters
- Latest activity:
- 2025 Q1
According to 2026 Q2 report, John Armitage doesn't hold any GE HealthCare Technologies Inc (GEHC) shares. To date, the estimated cost basis is nearly $85.45 for "buy" trades and estimated average "sell" price is $81.16. Egerton Capital first purchased GEHC in 2023 Q4, initially acquiring about 3.50M shares. Since the initial investment in GE HealthCare Technologies Inc (GEHC), Egerton Capital has made 5 more transactions.
When did John Armitage sell GE HealthCare Technologies Inc (GEHC)?
John Armitage sold off the entire GE HealthCare Technologies Inc (GEHC) position in 2025 Q1.
When did John Armitage buy GE HealthCare Technologies Inc (GEHC)?
John Armitage first invested in GE HealthCare Technologies Inc (GEHC) in 2023 Q4 at the reported quarter-end price of $77.32 per share.
What's the cost basis of Egerton Capital's GEHC stake?
The estimated cost basis for GE HealthCare Technologies Inc (GEHC) stake is around $85.45 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $85.45
- Weighted AVG sell price:
- $81.16
John Armitage's historical trades in GE HealthCare Technologies Inc
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q1
|
0.00%
|
0
|
$78.18
|
|
-100% (-4,572,382)
|
-4.13%
|
|
2024 Q4
|
4.13%
|
4,572,382
|
$78.18
|
$357,468,825
|
-19.50% (-1,107,639)
|
-0.87%
|
|
2024 Q3
|
5.38%
|
5,680,021
|
$93.85
|
$533,069,971
|
-22.80% (-1,677,864)
|
-1.59%
|
|
2024 Q2
|
5.79%
|
7,357,885
|
$77.92
|
$573,326,399
|
-15.49% (-1,348,969)
|
-1.02%
|
|
2024 Q1
|
7.65%
|
8,706,854
|
$90.91
|
$791,540,097
|
+149.02% (+5,210,342)
|
+4.58%
|
|
2023 Q4
|
2.93%
|
3,496,512
|
$77.32
|
$270,350,308
|
new
|
+2.93%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.